Article Versions Notes

Salgado ABdS, Magalhães RJP, Pontes RM, Barbosa EdS, Flores-Montero J, Sanoja-Flores L, Land MGP, Pimenta G, Dutra HdS, Costa ES, et al. Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil. Cancers. 2023; 15(5):1605. https://doi.org/10.3390/cancers15051605

Salgado, Anna Beatriz dos Santos, Roberto Jose Pessoa Magalhães, Robéria M. Pontes, Eduarda da Silva Barbosa, Juan Flores-Montero, Luzalba Sanoja-Flores, Marcelo Gerardin Poirot Land, Glicinia Pimenta, Hélio dos Santos Dutra, Elaine S. Costa, and et al. 2023. "Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil" Cancers 15, no. 5: 1605. https://doi.org/10.3390/cancers15051605

Salgado, A. B. d. S., Magalhães, R. J. P., Pontes, R. M., Barbosa, E. d. S., Flores-Montero, J., Sanoja-Flores, L., Land, M. G. P., Pimenta, G., Dutra, H. d. S., Costa, E. S., Orfao, A., & Maiolino, A. (2023). Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil. Cancers, 15(5), 1605. https://doi.org/10.3390/cancers15051605